| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR KIF6 KIF27 ANK3 GIT1 SYNE1 WASF3 ARFGEF2 GAS7 MYO1B NEB RHO KIF20A LRPPRC DST BRCA2 XIRP2 FMN1 STARD9 TLN1 PARVA CEP135 DIAPH2 MACF1 TLN2 DAAM1 DMD SNCG MYO15A TNNI3 UTRN | 3.20e-10 | 1099 | 155 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | actin binding | SYNE1 WASF3 GAS7 MYO1B NEB LRPPRC DST XIRP2 FMN1 TLN1 PARVA DIAPH2 MACF1 TLN2 DAAM1 DMD MYO15A TNNI3 UTRN | 6.19e-09 | 479 | 155 | 19 | GO:0003779 |
| GeneOntologyMolecularFunction | G protein-coupled photoreceptor activity | 7.45e-08 | 15 | 155 | 5 | GO:0008020 | |
| GeneOntologyMolecularFunction | photoreceptor activity | 1.52e-07 | 17 | 155 | 5 | GO:0009881 | |
| GeneOntologyMolecularFunction | actin filament binding | SYNE1 GAS7 MYO1B NEB LRPPRC XIRP2 TLN1 MACF1 TLN2 MYO15A TNNI3 | 1.66e-06 | 227 | 155 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | tubulin binding | TPR KIF6 KIF27 GIT1 KIF20A LRPPRC DST BRCA2 FMN1 STARD9 CEP135 MACF1 SNCG | 3.05e-05 | 428 | 155 | 13 | GO:0015631 |
| GeneOntologyMolecularFunction | vinculin binding | 1.24e-04 | 13 | 155 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ANK3 DSP MYO1B EPS15L1 DST USO1 TLN1 PARVA MACF1 TLN2 DMD ARHGAP18 UTRN RPL7A | 2.45e-04 | 599 | 155 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.20e-04 | 118 | 155 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | lamin binding | 4.06e-04 | 19 | 155 | 3 | GO:0005521 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 5.90e-04 | 5 | 155 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | microtubule binding | 6.92e-04 | 308 | 155 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP5PB KIF6 ATP7B KIF27 ERCC6L MYO1B MSH3 RAD50 KIF20A STARD9 MACF1 MYO15A DDX21 | 1.02e-03 | 614 | 155 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | cadherin binding | 1.35e-03 | 339 | 155 | 9 | GO:0045296 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 1.59e-06 | 4 | 153 | 3 | GO:0043578 | |
| GeneOntologyBiologicalProcess | somatic muscle development | 7.87e-06 | 6 | 153 | 3 | GO:0007525 | |
| GeneOntologyBiologicalProcess | microtubule-based process | TPR SEMG2 KIF6 KIF27 ANK3 GIT1 SUN1 APOB RHO KIF20A FSIP2 TBC1D32 LRPPRC DST BRCA2 STARD9 PDE4DIP CEP135 CCDC68 DNAI4 MACF1 CCDC40 | 1.16e-05 | 1058 | 153 | 22 | GO:0007017 |
| GeneOntologyBiologicalProcess | cellular response to radiation | 1.49e-05 | 194 | 153 | 9 | GO:0071478 | |
| GeneOntologyBiologicalProcess | regulation of ARF protein signal transduction | 2.31e-05 | 23 | 153 | 4 | GO:0032012 | |
| GeneOntologyBiologicalProcess | ARF protein signal transduction | 2.76e-05 | 24 | 153 | 4 | GO:0032011 | |
| GeneOntologyBiologicalProcess | phototransduction | 4.53e-05 | 53 | 153 | 5 | GO:0007602 | |
| GeneOntologyBiologicalProcess | detection of visible light | 6.45e-05 | 57 | 153 | 5 | GO:0009584 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | SEMG2 KIF6 KIF27 ANK3 SUN1 APOB KIF20A FSIP2 LRPPRC DST STARD9 DNAI4 CCDC40 | 8.12e-05 | 493 | 153 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR ANK3 GIT1 SUN1 RHO KIF20A FSIP2 TBC1D32 DST BRCA2 STARD9 PDE4DIP CEP135 CCDC68 DNAI4 CCDC40 | 9.25e-05 | 720 | 153 | 16 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of cytokinesis | 9.59e-05 | 99 | 153 | 6 | GO:0032465 | |
| GeneOntologyBiologicalProcess | cilium assembly | KIF27 SYNE1 KIAA0586 CC2D2B FSIP2 TBC1D32 CIBAR1 PARVA CEP135 DNAI4 UBXN10 CCDC40 | 1.22e-04 | 444 | 153 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | regulation of cell division | 1.31e-04 | 201 | 153 | 8 | GO:0051302 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | KIF27 DOCK11 SYNE1 WASF3 KIAA0586 CC2D2B FSIP2 TBC1D32 CIBAR1 PARVA CEP135 DNAI4 ARHGEF26 UBXN10 CCDC40 | 1.43e-04 | 670 | 153 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | nuclear matrix anchoring at nuclear membrane | 1.63e-04 | 3 | 153 | 2 | GO:0090292 | |
| GeneOntologyBiologicalProcess | cell projection assembly | KIF27 DOCK11 SYNE1 WASF3 KIAA0586 CC2D2B FSIP2 TBC1D32 CIBAR1 PARVA CEP135 DNAI4 ARHGEF26 UBXN10 CCDC40 | 1.81e-04 | 685 | 153 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | cilium organization | KIF27 SYNE1 KIAA0586 CC2D2B FSIP2 TBC1D32 CIBAR1 PARVA CEP135 DNAI4 UBXN10 CCDC40 | 2.32e-04 | 476 | 153 | 12 | GO:0044782 |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 2.63e-04 | 119 | 153 | 6 | GO:0006892 | |
| GeneOntologyBiologicalProcess | protein localization to cilium | 2.70e-04 | 77 | 153 | 5 | GO:0061512 | |
| GeneOntologyBiologicalProcess | detection of light stimulus | 2.70e-04 | 77 | 153 | 5 | GO:0009583 | |
| GeneOntologyCellularComponent | photoreceptor disc membrane | 1.26e-06 | 26 | 156 | 5 | GO:0097381 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF6 KIF27 ANK3 DSP KRT27 SYNE1 ARFGEF2 GAS7 MYO1B CMYA5 NEB KIF20A LRPPRC DST DPP9 XIRP2 FMN1 PDE4DIP PARVA DIAPH2 MACF1 DMD ARHGAP18 TNNI3 | 7.11e-06 | 1179 | 156 | 24 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF6 KIF27 ANK3 DSP KRT27 SYNE1 ARFGEF2 GAS7 MYO1B CMYA5 NEB KIF20A LRPPRC DST DPP9 XIRP2 FMN1 PDE4DIP PARVA DIAPH2 MACF1 DMD ARHGAP18 TNNI3 | 7.96e-06 | 1187 | 156 | 24 | GO:0099081 |
| GeneOntologyCellularComponent | cell leading edge | GIT1 DOCK8 CYTH3 WASF3 GAS7 DST DPP9 TLN1 PARVA MACF1 TLN2 DMD ARHGAP18 ARHGEF26 | 2.40e-05 | 500 | 156 | 14 | GO:0031252 |
| GeneOntologyCellularComponent | myofibril | 4.03e-05 | 273 | 156 | 10 | GO:0030016 | |
| GeneOntologyCellularComponent | cilium | KIF27 KIAA0586 OPN1LW ARFGEF2 OPN1MW RHO CC2D2B OPN1MW2 NEK4 FSIP2 TBC1D32 OPN1MW3 PROM2 CIBAR1 CCDC68 DNAI4 DAAM1 UBXN10 CCDC40 | 4.19e-05 | 898 | 156 | 19 | GO:0005929 |
| GeneOntologyCellularComponent | contractile muscle fiber | 6.68e-05 | 290 | 156 | 10 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 1.09e-04 | 249 | 156 | 9 | GO:0030017 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ANKRD26 GAS7 MYO1B NEB DST XIRP2 FMN1 PARVA DIAPH2 MACF1 TLN2 DAAM1 MYO15A TNNI3 | 1.10e-04 | 576 | 156 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF6 KIF27 DSP KRT27 ARFGEF2 GAS7 MYO1B KIF20A LRPPRC DST DPP9 FMN1 PDE4DIP DIAPH2 MACF1 DMD ARHGAP18 | 4.06e-04 | 899 | 156 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | costamere | 5.66e-04 | 22 | 156 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | intermediate-density lipoprotein particle | 8.14e-04 | 6 | 156 | 2 | GO:0034363 | |
| GeneOntologyCellularComponent | ruffle | 9.20e-04 | 206 | 156 | 7 | GO:0001726 | |
| GeneOntologyCellularComponent | Z disc | 9.60e-04 | 151 | 156 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.30e-03 | 108 | 156 | 5 | GO:0034708 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.47e-03 | 111 | 156 | 5 | GO:0001750 | |
| GeneOntologyCellularComponent | I band | 1.56e-03 | 166 | 156 | 6 | GO:0031674 | |
| GeneOntologyCellularComponent | intercalated disc | 1.68e-03 | 68 | 156 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | MLL1 complex | 1.73e-03 | 32 | 156 | 3 | GO:0071339 | |
| GeneOntologyCellularComponent | MLL1/2 complex | 1.89e-03 | 33 | 156 | 3 | GO:0044665 | |
| MousePheno | abnormal neuromuscular synapse morphology | 2.87e-05 | 95 | 130 | 7 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 3.51e-05 | 98 | 130 | 7 | MP:0001051 | |
| Domain | Spectrin_repeat | 1.16e-07 | 29 | 154 | 6 | IPR002017 | |
| Domain | SPEC | 2.16e-07 | 32 | 154 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.16e-07 | 32 | 154 | 6 | IPR018159 | |
| Domain | Opsin_red/grn | 5.50e-07 | 3 | 154 | 3 | IPR000378 | |
| Domain | ARM-type_fold | DOCK11 INTS7 DOCK8 ARFGEF2 APOB ARFGEF3 AP4E1 THADA USO1 PIK3CG DIAPH2 DAAM1 NIPBL SYMPK | 8.60e-07 | 339 | 154 | 14 | IPR016024 |
| Domain | OPSIN | 8.98e-07 | 10 | 154 | 4 | PS00238 | |
| Domain | Spectrin | 1.07e-06 | 23 | 154 | 5 | PF00435 | |
| Domain | ACTININ_2 | 1.07e-06 | 23 | 154 | 5 | PS00020 | |
| Domain | ACTININ_1 | 1.07e-06 | 23 | 154 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.07e-06 | 23 | 154 | 5 | IPR001589 | |
| Domain | Opsin | 1.40e-06 | 11 | 154 | 4 | IPR001760 | |
| Domain | SUZ | 2.19e-06 | 4 | 154 | 3 | IPR024771 | |
| Domain | SUZ | 2.19e-06 | 4 | 154 | 3 | PS51673 | |
| Domain | - | 1.08e-05 | 6 | 154 | 3 | 3.90.1290.10 | |
| Domain | CH | 1.58e-05 | 65 | 154 | 6 | SM00033 | |
| Domain | Plectin | 1.88e-05 | 7 | 154 | 3 | PF00681 | |
| Domain | Plectin_repeat | 1.88e-05 | 7 | 154 | 3 | IPR001101 | |
| Domain | PLEC | 1.88e-05 | 7 | 154 | 3 | SM00250 | |
| Domain | CH | 2.42e-05 | 70 | 154 | 6 | PF00307 | |
| Domain | - | 2.62e-05 | 71 | 154 | 6 | 1.10.418.10 | |
| Domain | CH | 3.08e-05 | 73 | 154 | 6 | PS50021 | |
| Domain | CH-domain | 3.59e-05 | 75 | 154 | 6 | IPR001715 | |
| Domain | R3H | 4.45e-05 | 9 | 154 | 3 | SM00393 | |
| Domain | - | 6.75e-05 | 2 | 154 | 2 | 1.20.1420.10 | |
| Domain | VBS | 6.75e-05 | 2 | 154 | 2 | PF08913 | |
| Domain | Dystrophin | 6.75e-05 | 2 | 154 | 2 | IPR016344 | |
| Domain | Vinculin-bd_dom | 6.75e-05 | 2 | 154 | 2 | IPR015009 | |
| Domain | Talin_cent | 6.75e-05 | 2 | 154 | 2 | IPR015224 | |
| Domain | Talin_middle | 6.75e-05 | 2 | 154 | 2 | PF09141 | |
| Domain | R3H | 8.64e-05 | 11 | 154 | 3 | PS51061 | |
| Domain | R3H | 8.64e-05 | 11 | 154 | 3 | PF01424 | |
| Domain | - | 8.64e-05 | 11 | 154 | 3 | 3.30.1370.50 | |
| Domain | R3H_dom | 8.64e-05 | 11 | 154 | 3 | IPR001374 | |
| Domain | Talin-1 | 2.02e-04 | 3 | 154 | 2 | IPR015710 | |
| Domain | SUZ | 2.02e-04 | 3 | 154 | 2 | PF12752 | |
| Domain | FH2 | 2.33e-04 | 15 | 154 | 3 | PS51444 | |
| Domain | FH2_Formin | 2.33e-04 | 15 | 154 | 3 | IPR015425 | |
| Domain | FH2 | 2.33e-04 | 15 | 154 | 3 | PF02181 | |
| Domain | FH2 | 2.33e-04 | 15 | 154 | 3 | SM00498 | |
| Domain | SEC7 | 2.85e-04 | 16 | 154 | 3 | PS50190 | |
| Domain | Sec7 | 2.85e-04 | 16 | 154 | 3 | SM00222 | |
| Domain | Sec7_dom | 2.85e-04 | 16 | 154 | 3 | IPR000904 | |
| Domain | Kinesin_motor_CS | 3.55e-04 | 41 | 154 | 4 | IPR019821 | |
| Domain | ILWEQ_dom | 4.01e-04 | 4 | 154 | 2 | IPR002558 | |
| Domain | ILWEQ | 4.01e-04 | 4 | 154 | 2 | SM00307 | |
| Domain | DCB_dom | 4.01e-04 | 4 | 154 | 2 | IPR032629 | |
| Domain | FERM_f0 | 4.01e-04 | 4 | 154 | 2 | PF16511 | |
| Domain | ILWEQ | 4.01e-04 | 4 | 154 | 2 | PD011820 | |
| Domain | - | 4.01e-04 | 4 | 154 | 2 | 1.20.1410.10 | |
| Domain | Sec7_C | 4.01e-04 | 4 | 154 | 2 | IPR015403 | |
| Domain | DUF1981 | 4.01e-04 | 4 | 154 | 2 | PF09324 | |
| Domain | I_LWEQ | 4.01e-04 | 4 | 154 | 2 | PF01608 | |
| Domain | I_LWEQ | 4.01e-04 | 4 | 154 | 2 | PS50945 | |
| Domain | FERM_f0 | 4.01e-04 | 4 | 154 | 2 | IPR032425 | |
| Domain | DCB | 4.01e-04 | 4 | 154 | 2 | PF16213 | |
| Domain | Ank_2 | 4.20e-04 | 215 | 154 | 8 | PF12796 | |
| Domain | - | 4.67e-04 | 44 | 154 | 4 | 3.40.850.10 | |
| Domain | Kinesin | 4.67e-04 | 44 | 154 | 4 | PF00225 | |
| Domain | KISc | 4.67e-04 | 44 | 154 | 4 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 4.67e-04 | 44 | 154 | 4 | PS00411 | |
| Domain | Kinesin_motor_dom | 4.67e-04 | 44 | 154 | 4 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 4.67e-04 | 44 | 154 | 4 | PS50067 | |
| Domain | WW | 6.02e-04 | 47 | 154 | 4 | PF00397 | |
| Domain | Ank | 6.18e-04 | 228 | 154 | 8 | PF00023 | |
| Domain | WW | 6.52e-04 | 48 | 154 | 4 | SM00456 | |
| Domain | WW_DOMAIN_1 | 8.22e-04 | 51 | 154 | 4 | PS01159 | |
| Domain | WW_DOMAIN_2 | 8.22e-04 | 51 | 154 | 4 | PS50020 | |
| Domain | WW_dom | 8.85e-04 | 52 | 154 | 4 | IPR001202 | |
| Domain | GAR | 9.91e-04 | 6 | 154 | 2 | PS51460 | |
| Domain | GAS2 | 9.91e-04 | 6 | 154 | 2 | PF02187 | |
| Domain | DUF3398 | 9.91e-04 | 6 | 154 | 2 | PF11878 | |
| Domain | EF-hand_dom_typ1 | 9.91e-04 | 6 | 154 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 9.91e-04 | 6 | 154 | 2 | IPR015154 | |
| Domain | - | 9.91e-04 | 6 | 154 | 2 | 3.30.920.20 | |
| Domain | DOCK_C/D_N | 9.91e-04 | 6 | 154 | 2 | IPR021816 | |
| Domain | EF-hand_2 | 9.91e-04 | 6 | 154 | 2 | PF09068 | |
| Domain | EF-hand_3 | 9.91e-04 | 6 | 154 | 2 | PF09069 | |
| Domain | GAS_dom | 9.91e-04 | 6 | 154 | 2 | IPR003108 | |
| Domain | GAS2 | 9.91e-04 | 6 | 154 | 2 | SM00243 | |
| Domain | - | 1.07e-03 | 248 | 154 | 8 | 1.25.40.20 | |
| Domain | ANK | 1.15e-03 | 251 | 154 | 8 | SM00248 | |
| Domain | ANK_REPEAT | 1.21e-03 | 253 | 154 | 8 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 1.24e-03 | 254 | 154 | 8 | IPR020683 | |
| Domain | ANK_REP_REGION | 1.24e-03 | 254 | 154 | 8 | PS50297 | |
| Domain | Vinculin/catenin | 1.38e-03 | 7 | 154 | 2 | IPR006077 | |
| Domain | Ankyrin_rpt | 1.51e-03 | 262 | 154 | 8 | IPR002110 | |
| Domain | DAD_dom | 1.83e-03 | 8 | 154 | 2 | IPR014767 | |
| Domain | DAD | 1.83e-03 | 8 | 154 | 2 | PS51231 | |
| Domain | Retinal_BS | 1.83e-03 | 8 | 154 | 2 | IPR027430 | |
| Domain | Drf_GBD | 2.34e-03 | 9 | 154 | 2 | PF06371 | |
| Domain | Drf_FH3 | 2.34e-03 | 9 | 154 | 2 | PF06367 | |
| Domain | FH3_dom | 2.34e-03 | 9 | 154 | 2 | IPR010472 | |
| Domain | GTPase-bd | 2.34e-03 | 9 | 154 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 2.34e-03 | 9 | 154 | 2 | SM01139 | |
| Domain | Drf_GBD | 2.34e-03 | 9 | 154 | 2 | SM01140 | |
| Domain | Prefoldin | 2.96e-03 | 72 | 154 | 4 | IPR009053 | |
| Domain | GBD/FH3_dom | 3.54e-03 | 11 | 154 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 3.54e-03 | 11 | 154 | 2 | PS51232 | |
| Domain | DHR-1_domain | 3.54e-03 | 11 | 154 | 2 | IPR027007 | |
| Domain | DHR_2 | 3.54e-03 | 11 | 154 | 2 | PS51651 | |
| Pathway | REACTOME_OPSINS | 8.80e-07 | 10 | 116 | 4 | MM15063 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.31e-05 | 42 | 116 | 5 | M41828 | |
| Pathway | REACTOME_RND1_GTPASE_CYCLE | 2.59e-05 | 43 | 116 | 5 | MM15679 | |
| Pathway | REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION | 2.95e-05 | 8 | 116 | 3 | MM14880 | |
| Pathway | REACTOME_OPSINS | 4.40e-05 | 9 | 116 | 3 | M6285 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | GIT1 DOCK11 DSP DOCK8 WASF3 ANKRD26 TFRC KIDINS220 DST DIAPH2 DAAM1 ARHGAP18 ARHGEF26 | 6.47e-05 | 439 | 116 | 13 | MM15595 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | GIT1 DOCK11 DSP DOCK8 WASF3 ANKRD26 TFRC KIDINS220 DST DIAPH2 DAAM1 ARHGAP18 ARHGEF26 | 8.31e-05 | 450 | 116 | 13 | M27078 |
| Pubmed | GIT1 DSP SYNE1 ANKRD26 GAS7 ZNF619 CMYA5 NEB GPATCH2L LRPPRC DST XIRP2 RABEP1 TLN1 PDE4DIP MACF1 MGA UTRN | 1.92e-11 | 497 | 160 | 18 | 23414517 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR METTL3 KIF27 ERCC6L DSP DOCK8 RBM10 ARFGEF2 PRPF8 RAD50 USO1 ANAPC1 TLN1 PARVA MACF1 TLN2 DDX21 NIPBL SYMPK | 3.04e-11 | 582 | 160 | 19 | 20467437 |
| Pubmed | TPR DSP SYNE1 MYO1B NEB PRPF8 RAD50 DST MACF1 EEA1 DMD DDX21 RPL7A | 7.59e-11 | 234 | 160 | 13 | 36243803 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB TPR KIF27 DSP VPS13C SYNE1 KIAA0586 MYO1B APOB MSH3 CMYA5 PRPF8 TFRC RAD50 LRPPRC THADA KIDINS220 USO1 ANAPC1 STARD9 TLN1 TLN2 EEA1 HARS1 TDRD6 DDX21 NIPBL RPL7A | 8.21e-11 | 1425 | 160 | 28 | 30948266 |
| Pubmed | KDM3A ANK3 GIT1 DSP CYTH3 SYNE1 LRSAM1 ARFGEF2 GAS7 MSH3 ZNF619 CMYA5 PRPF8 EPS15L1 DST RABEP1 PDE4DIP OSBPL8 MACF1 TLN2 ANKRD36 DGCR8 HARS1 R3HDM1 UTRN NIPBL | 2.27e-10 | 1285 | 160 | 26 | 35914814 | |
| Pubmed | Human L- and M-opsins restore M-cone function in a mouse model for human blue cone monochromacy. | 4.31e-10 | 4 | 160 | 4 | 29386880 | |
| Pubmed | TPR ANK3 GIT1 DOCK11 CYTH3 SYNE1 RAD50 LRPPRC EPS15L1 DST ANAPC1 LZTS1 RABEP1 PDE4DIP NUFIP2 DIAPH2 MACF1 TLN2 TAF4 ARHGEF26 MGA NIPBL | 6.95e-10 | 963 | 160 | 22 | 28671696 | |
| Pubmed | Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. | 2.15e-09 | 5 | 160 | 4 | 2937147 | |
| Pubmed | 2.15e-09 | 5 | 160 | 4 | 11055434 | ||
| Pubmed | Variations in photoreceptor throughput to mouse visual cortex and the unique effects on tuning. | 2.15e-09 | 5 | 160 | 4 | 34099749 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR ERCC6L DSP RBM10 PARG ANKRD26 MYO1B PRPF8 ECH1 RAD50 EPS15L1 DST SMG7 RABEP1 TLN1 NUFIP2 MACF1 DDX21 UTRN NIPBL RPL7A | 2.33e-09 | 934 | 160 | 21 | 33916271 |
| Pubmed | TPR ANK3 ERCC6L DSP ANKRD26 MYO1B TFRC LRPPRC EPS15L1 KIDINS220 DST USO1 TLN1 NUFIP2 OSBPL8 MACF1 ARHGEF26 RPL7A | 5.40e-09 | 708 | 160 | 18 | 39231216 | |
| Pubmed | DSP RBM10 MYO1B ESCO1 LRPPRC USO1 ANAPC1 OSBPL8 TAF4 DDX21 MGA NIPBL | 5.67e-09 | 272 | 160 | 12 | 31010829 | |
| Pubmed | TPR KDM3A ANK3 ERCC6L DSP RBM10 RAD50 EPS15L1 SMG7 ANAPC1 RABEP1 TLN1 NUFIP2 TAF4 MGA SYMPK | 6.01e-09 | 549 | 160 | 16 | 38280479 | |
| Pubmed | Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. | 6.42e-09 | 6 | 160 | 4 | 8872469 | |
| Pubmed | 6.42e-09 | 6 | 160 | 4 | 17436273 | ||
| Pubmed | TPR DSP MYO1B PRPF8 RAD50 LRPPRC DST ANAPC1 TLN1 NUFIP2 OSBPL8 MACF1 DDX21 UTRN NIPBL RPL7A SYMPK | 1.04e-08 | 653 | 160 | 17 | 22586326 | |
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 12176734 | ||
| Pubmed | 1.49e-08 | 7 | 160 | 4 | 19332056 | ||
| Pubmed | Retarded developmental expression and patterning of retinal cone opsins in hypothyroid mice. | 1.49e-08 | 7 | 160 | 4 | 18974269 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 METTL3 GIT1 DSP LRSAM1 ANKRD26 MYO1B RAD50 ARFGEF3 SMG7 BRCA2 USO1 ANAPC1 RABEP1 MACF1 HSF2 | 1.57e-08 | 588 | 160 | 16 | 38580884 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | GIT1 ERCC6L DOCK11 DSP ANKRD26 NEK4 ARFGEF3 FSIP2 LRPPRC DST USO1 STARD9 RABEP1 OSBPL8 MACF1 R3HDM1 UTRN ABTB2 EDRF1 | 1.92e-08 | 861 | 160 | 19 | 36931259 |
| Pubmed | ANK3 CCDC186 VPS13C ANKRD26 ARFGEF2 APOB KIF20A ARFGEF3 AP4E1 EPS15L1 PPP2R3A THADA KIDINS220 DST USO1 DGCR8 MGA RPL7A | 2.24e-08 | 777 | 160 | 18 | 35844135 | |
| Pubmed | 2.84e-08 | 20 | 160 | 5 | 21689717 | ||
| Pubmed | Localization of the mdx mutation within the mouse dystrophin gene. | 2.98e-08 | 8 | 160 | 4 | 2903046 | |
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 21813673 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 20203194 | ||
| Pubmed | Tubby is required for trafficking G protein-coupled receptors to neuronal cilia. | 2.98e-08 | 8 | 160 | 4 | 23351594 | |
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 10725384 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 33007388 | ||
| Pubmed | 2.98e-08 | 8 | 160 | 4 | 12651948 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP5PB ANK3 DSP SYNE1 MYO1B PRPF8 ECH1 TFRC LRPPRC DST TLN1 MACF1 EEA1 HARS1 ARHGAP18 MYO15A UTRN RPL7A | 3.97e-08 | 807 | 160 | 18 | 30575818 |
| Pubmed | ATP5PB ANK3 GIT1 DSP DOCK8 SYNE1 ARFGEF2 LRPPRC EPS15L1 KIDINS220 DST USO1 LZTS1 TLN1 PDE4DIP NUFIP2 OSBPL8 MACF1 TLN2 LSAMP CPNE4 DMD UTRN RPL7A | 4.43e-08 | 1431 | 160 | 24 | 37142655 | |
| Pubmed | 5.34e-08 | 9 | 160 | 4 | 28370415 | ||
| Pubmed | IFT20 is required for opsin trafficking and photoreceptor outer segment development. | 5.34e-08 | 9 | 160 | 4 | 21307337 | |
| Pubmed | 5.34e-08 | 9 | 160 | 4 | 1973136 | ||
| Pubmed | Retinal dystrophy resulting from ablation of RXR alpha in the mouse retinal pigment epithelium. | 5.34e-08 | 9 | 160 | 4 | 14742273 | |
| Pubmed | 5.34e-08 | 9 | 160 | 4 | 25296752 | ||
| Pubmed | ATP5PB MED6 METTL3 GIT1 PARG ANKRD26 ECH1 RAD50 KIF20A EPS15L1 DST TLN1 NUFIP2 CEP135 UTRN EDRF1 | 5.61e-08 | 645 | 160 | 16 | 25281560 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP5PB TPR DSP SYNE1 RBM10 SUN1 MYO1B PRPF8 TFRC RAD50 LRPPRC DST TLN1 MACF1 EEA1 DDX21 MGA UTRN NIPBL RPL7A | 5.87e-08 | 1024 | 160 | 20 | 24711643 |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ANK3 MYO1B EPS15L1 KIDINS220 DST USO1 PROM2 FMN1 TLN1 PARVA MACF1 DAAM1 ARHGAP18 UTRN RPL7A | 6.22e-08 | 565 | 160 | 15 | 25468996 |
| Pubmed | TPR ANK3 DSP CCDC186 SYNE1 GAS7 NEB MAPKAPK5 DST DIAPH2 MACF1 DMD MGA RPL7A | 6.46e-08 | 486 | 160 | 14 | 20936779 | |
| Pubmed | ATP5PB TPR ANK3 DSP SYNE1 CMYA5 NEB PRPF8 LRPPRC DST TLN1 MACF1 CPNE4 HARS1 DMD DDX21 UTRN RPL7A | 7.76e-08 | 844 | 160 | 18 | 25963833 | |
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 8449515 | ||
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 32236127 | ||
| Pubmed | Mapping of the phosphorylase kinase alpha subunit gene on the mouse X chromosome. | 8.87e-08 | 10 | 160 | 4 | 1973380 | |
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 1964443 | ||
| Pubmed | Fam151b, the mouse homologue of C.elegans menorin gene, is essential for retinal function. | 8.87e-08 | 10 | 160 | 4 | 31949211 | |
| Pubmed | 8.87e-08 | 10 | 160 | 4 | 1684949 | ||
| Pubmed | Multiple hypothalamic cell populations encoding distinct visual information. | 9.56e-08 | 3 | 160 | 3 | 21224225 | |
| Pubmed | Circadian Regulation of the Rod Contribution to Mesopic Vision in Mice. | 9.56e-08 | 3 | 160 | 3 | 36216501 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 34111401 | ||
| Pubmed | Gene-based Therapy in a Mouse Model of Blue Cone Monochromacy. | 9.56e-08 | 3 | 160 | 3 | 28751656 | |
| Pubmed | The molecular genetics and evolution of red and green color vision in vertebrates. | 9.56e-08 | 3 | 160 | 3 | 11545071 | |
| Pubmed | Co-expression of murine opsins facilitates identifying the site of cone adaptation. | 9.56e-08 | 3 | 160 | 3 | 12511072 | |
| Pubmed | Molecular determinants of human red/green color discrimination. | 9.56e-08 | 3 | 160 | 3 | 8185948 | |
| Pubmed | X-linked cone dystrophy caused by mutation of the red and green cone opsins. | 9.56e-08 | 3 | 160 | 3 | 20579627 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 38410159 | ||
| Pubmed | Chloride-dependent spectral tuning mechanism of L-group cone visual pigments. | 9.56e-08 | 3 | 160 | 3 | 23350963 | |
| Pubmed | Distinct contributions of rod, cone, and melanopsin photoreceptors to encoding irradiance. | 9.56e-08 | 3 | 160 | 3 | 20471354 | |
| Pubmed | Spectral tuning of a circadian photopigment in a subterranean 'blind' mammal (Spalax ehrenbergi). | 9.56e-08 | 3 | 160 | 3 | 10567724 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 14500905 | ||
| Pubmed | Rescue of M-cone Function in Aged Opn1mw-/- Mice, a Model for Late-Stage Blue Cone Monochromacy. | 9.56e-08 | 3 | 160 | 3 | 31469404 | |
| Pubmed | Mechanisms of spectral tuning in the mouse green cone pigment. | 9.56e-08 | 3 | 160 | 3 | 9238068 | |
| Pubmed | Emergence of novel color vision in mice engineered to express a human cone photopigment. | 9.56e-08 | 3 | 160 | 3 | 17379811 | |
| Pubmed | 9.56e-08 | 3 | 160 | 3 | 7958444 | ||
| Pubmed | ATP5PB KDM3A MED6 ATP7B GIT1 ERCC6L DOCK8 ARFGEF2 MSH3 PRPF8 ECH1 RAD50 LRPPRC EPS15L1 KIDINS220 USO1 PIK3CG NUFIP2 OSBPL8 DAAM1 DDX21 | 1.07e-07 | 1168 | 160 | 21 | 19946888 | |
| Pubmed | 1.39e-07 | 11 | 160 | 4 | 1572636 | ||
| Pubmed | 1.39e-07 | 11 | 160 | 4 | 24421398 | ||
| Pubmed | 2.07e-07 | 12 | 160 | 4 | 1679744 | ||
| Pubmed | MAP4K4 is involved in the neuronal development of retinal photoreceptors. | 2.07e-07 | 12 | 160 | 4 | 37290629 | |
| Pubmed | Genetic and physical mapping of the biglycan gene on the mouse X chromosome. | 2.07e-07 | 12 | 160 | 4 | 8093671 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 2.07e-07 | 12 | 160 | 4 | 2561974 | |
| Pubmed | The expression analysis of Sfrs10 and Celf4 during mouse retinal development. | 2.99e-07 | 13 | 160 | 4 | 23932931 | |
| Pubmed | Essential functions of synapsins I and II in synaptic vesicle regulation. | 2.99e-07 | 13 | 160 | 4 | 7777057 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | TPR DSP RBM10 PRPF8 TFRC KIF20A EPS15L1 KIDINS220 TLN1 NUFIP2 | 3.39e-07 | 256 | 160 | 10 | 33397691 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.60e-07 | 197 | 160 | 9 | 20811636 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 ANK3 RASA2 VPS13C WASF3 ECH1 AHDC1 ESCO1 ARFGEF3 LRPPRC EPS15L1 PPP2R3A THADA KIDINS220 DPP9 SMG7 PROM2 RABEP1 MACF1 TAF4 DAAM1 ARHGEF26 UTRN | 3.72e-07 | 1489 | 160 | 23 | 28611215 |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 28103478 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 3303660 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 26438865 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 17249565 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 38060327 | ||
| Pubmed | Contribution of M-opsin-based color vision to refractive development in mice. | 3.81e-07 | 4 | 160 | 3 | 34126082 | |
| Pubmed | Expressions of rod and cone photoreceptor-like proteins in human epidermis. | 3.81e-07 | 4 | 160 | 3 | 19493002 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 31461375 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 8088841 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 31846668 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 8954775 | ||
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 16567464 | ||
| Pubmed | S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant. | 3.81e-07 | 4 | 160 | 3 | 24801621 | |
| Pubmed | Melanopsin Contributions to the Representation of Images in the Early Visual System. | 3.81e-07 | 4 | 160 | 3 | 28528909 | |
| Pubmed | 3.81e-07 | 4 | 160 | 3 | 25308073 | ||
| Pubmed | Disruption in murine Eml1 perturbs retinal lamination during early development. | 4.17e-07 | 14 | 160 | 4 | 32221352 | |
| Pubmed | 4.17e-07 | 14 | 160 | 4 | 37033230 | ||
| Pubmed | 4.17e-07 | 14 | 160 | 4 | 23171847 | ||
| Pubmed | Genetic mapping of the mouse X chromosome in the region homologous to human Xq27-Xq28. | 4.17e-07 | 14 | 160 | 4 | 1674728 | |
| Pubmed | 4.17e-07 | 14 | 160 | 4 | 16868010 | ||
| Pubmed | Mapping of a liver phosphorylase kinase alpha-subunit gene on the mouse X chromosome. | 4.17e-07 | 14 | 160 | 4 | 8432533 | |
| Pubmed | 4.17e-07 | 14 | 160 | 4 | 30924851 | ||
| Interaction | STX6 interactions | SEMG2 ANK3 ANKRD26 ARFGEF2 MYO1B TFRC AP4E1 EPS15L1 KIDINS220 DST USO1 RABEP1 OSBPL8 MACF1 EEA1 UTRN | 4.19e-07 | 448 | 156 | 16 | int:STX6 |
| Interaction | TERF1 interactions | ARPP21 GIT1 LRSAM1 GNMT RAD50 DST BRCA2 MACROD2 TDRD6 DMD SNCG DDX21 UTRN RPL7A | 5.44e-07 | 347 | 156 | 14 | int:TERF1 |
| Interaction | GOLGA1 interactions | ATP7B ERCC6L KRT27 ANKRD26 ARFGEF3 AP4E1 DST SMG7 LZTS1 MACF1 | 1.66e-06 | 183 | 156 | 10 | int:GOLGA1 |
| Interaction | RHOQ interactions | GIT1 DOCK11 DOCK8 VPS13C ANKRD26 TFRC ARFGEF3 KIDINS220 DST CIBAR1 PARVA DIAPH2 OSBPL8 DAAM1 UTRN | 1.85e-06 | 442 | 156 | 15 | int:RHOQ |
| Interaction | CDC5L interactions | TPR ERCC6L DSP DOCK8 SYNE1 RBM10 PRPF8 RAD50 NEK4 DST USO1 ANAPC1 TLN1 PDE4DIP PARVA MACF1 TLN2 DDX21 NIPBL RPL7A SYMPK | 2.85e-06 | 855 | 156 | 21 | int:CDC5L |
| Interaction | NAA40 interactions | TPR ERCC6L DSP RBM10 PARG ANKRD26 MYO1B PRPF8 ECH1 RAD50 EPS15L1 DST SMG7 RABEP1 TLN1 ANGEL2 NUFIP2 MACF1 DDX21 UTRN NIPBL RPL7A | 6.65e-06 | 978 | 156 | 22 | int:NAA40 |
| Interaction | PHLPP1 interactions | TPR DSP RBM10 CMYA5 NEB PRPF8 TFRC KIF20A EPS15L1 KIDINS220 TLN1 NUFIP2 | 1.14e-05 | 333 | 156 | 12 | int:PHLPP1 |
| Interaction | KCNA3 interactions | TPR ANK3 ERCC6L DSP ANKRD26 MYO1B TFRC RAD50 LRPPRC EPS15L1 KIDINS220 DST USO1 TLN1 NUFIP2 OSBPL8 MACF1 TLN2 ARHGEF26 RPL7A | 1.35e-05 | 871 | 156 | 20 | int:KCNA3 |
| Interaction | EPB41L4A interactions | 1.36e-05 | 140 | 156 | 8 | int:EPB41L4A | |
| Interaction | TERF2 interactions | SYNE1 GNMT RAD50 DST BRCA2 TLN1 MACROD2 MACF1 TDRD6 DMD DDX21 UTRN | 1.40e-05 | 340 | 156 | 12 | int:TERF2 |
| Interaction | PHF21A interactions | TPR DSP KRT27 TUFT1 RAD50 DST BRCA2 USO1 ANAPC1 RABEP1 MGA UTRN | 1.53e-05 | 343 | 156 | 12 | int:PHF21A |
| Interaction | SNAPC4 interactions | 2.73e-05 | 76 | 156 | 6 | int:SNAPC4 | |
| Interaction | KDM1A interactions | ATP5PB TPR CCDC121 DSP CCDC90B ESCO1 GPATCH2L TUFT1 RAD50 DST SMG7 BRCA2 USO1 ANAPC1 LZTS1 RABEP1 PDE4DIP MGA UTRN SYMPK | 4.05e-05 | 941 | 156 | 20 | int:KDM1A |
| Interaction | LYN interactions | ANGPT2 ANK3 DSP ANKRD26 MYO1B PRPF8 TFRC KIF20A KIDINS220 DST PIK3CG GAB3 MACF1 DMD DDX21 UTRN RPL7A | 4.44e-05 | 720 | 156 | 17 | int:LYN |
| Interaction | H2BC9 interactions | ERCC6L DSP MSH3 NEB PRPF8 FSIP2 FHAD1 DST XIRP2 PDE4DIP ANKRD36 TAF4 RPL7A | 4.54e-05 | 446 | 156 | 13 | int:H2BC9 |
| Interaction | LAMTOR1 interactions | ATP7B CCDC186 VPS13C ARFGEF2 CCDC90B TFRC ARFGEF3 AP4E1 KIDINS220 DST RABEP1 NUFIP2 DIAPH2 OSBPL8 EEA1 DMD EDRF1 | 4.60e-05 | 722 | 156 | 17 | int:LAMTOR1 |
| Interaction | RAB4A interactions | ATP7B VPS13C SYNE1 SUN1 ARFGEF2 TFRC AP4E1 KIDINS220 DST RABEP1 DIAPH2 OSBPL8 EEA1 | 5.82e-05 | 457 | 156 | 13 | int:RAB4A |
| Interaction | SYCE1 interactions | 5.98e-05 | 127 | 156 | 7 | int:SYCE1 | |
| Interaction | SIRT7 interactions | TPR DSP MYO1B PRPF8 RAD50 LRPPRC DST ANAPC1 TLN1 NUFIP2 OSBPL8 MACF1 DDX21 UTRN NIPBL RPL7A SYMPK | 6.65e-05 | 744 | 156 | 17 | int:SIRT7 |
| Interaction | RAC2 interactions | GIT1 DOCK11 SUN1 ARFGEF2 MYO1B TFRC FHAD1 KIDINS220 DST PARVA DIAPH2 OSBPL8 MACF1 TLN2 DAAM1 UTRN | 7.07e-05 | 674 | 156 | 16 | int:RAC2 |
| Interaction | KIF15 interactions | 9.08e-05 | 94 | 156 | 6 | int:KIF15 | |
| Interaction | DUSP26 interactions | 9.31e-05 | 59 | 156 | 5 | int:DUSP26 | |
| Interaction | AGR2 interactions | ATP5PB ANK3 DSP SYNE1 CCDC90B MYO1B PRPF8 ECH1 TFRC LRPPRC DST TLN1 MACF1 EEA1 HARS1 ARHGAP18 MYO15A UTRN RPL7A | 1.14e-04 | 934 | 156 | 19 | int:AGR2 |
| Interaction | NUDCD2 interactions | DAPL1 DSP DOCK8 SYNE1 MYO1B PRPF8 TFRC TBC1D32 LRPPRC DDX21 RPL7A SYMPK | 1.18e-04 | 424 | 156 | 12 | int:NUDCD2 |
| Interaction | RHOJ interactions | GIT1 DOCK11 DOCK8 VPS13C SUN1 ANKRD26 ARFGEF2 TFRC ARFGEF3 KIDINS220 DIAPH2 OSBPL8 MACF1 DAAM1 UTRN | 1.22e-04 | 633 | 156 | 15 | int:RHOJ |
| Interaction | ACTA1 interactions | 1.53e-04 | 371 | 156 | 11 | int:ACTA1 | |
| Interaction | CEACAM16 interactions | 1.56e-04 | 14 | 156 | 3 | int:CEACAM16 | |
| Interaction | LATS1 interactions | ATP5PB RBM10 ANKRD26 MYO1B APOC3 NEB SMG7 XIRP2 ANAPC1 TAF4 R3HDM1 MGA | 1.67e-04 | 440 | 156 | 12 | int:LATS1 |
| Interaction | ETV2 interactions | 1.78e-04 | 3 | 156 | 2 | int:ETV2 | |
| Interaction | SYNE3 interactions | VPS13C SUN1 ANKRD26 TFRC KIDINS220 DST SMG7 BRCA2 ANAPC1 ETAA1 OSBPL8 MACF1 | 1.82e-04 | 444 | 156 | 12 | int:SYNE3 |
| Interaction | FBXO42 interactions | 1.92e-04 | 259 | 156 | 9 | int:FBXO42 | |
| Interaction | TNIK interactions | TPR ANK3 GIT1 DOCK11 SYNE1 DST LZTS1 PDE4DIP MACF1 HARS1 MGA | 1.92e-04 | 381 | 156 | 11 | int:TNIK |
| Interaction | TEDC2 interactions | 2.07e-04 | 206 | 156 | 8 | int:TEDC2 | |
| GeneFamily | Opsin receptors | 2.00e-09 | 11 | 99 | 5 | 215 | |
| GeneFamily | EF-hand domain containing|Plakins | 8.74e-06 | 8 | 99 | 3 | 939 | |
| GeneFamily | Ankyrin repeat domain containing | 5.51e-05 | 242 | 99 | 8 | 403 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.16e-04 | 46 | 99 | 4 | 622 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 9.46e-04 | 206 | 99 | 6 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.59e-03 | 50 | 99 | 3 | 1293 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM3A PHF20 PARG WASF3 MYO1B R3HDM2 MSH3 AHDC1 NEK4 LRPPRC PPP2R3A KIDINS220 DST BRCA2 CEP135 OSBPL8 MACF1 TAF4 DAAM1 DMD R3HDM1 DDX21 NIPBL | 1.80e-09 | 856 | 157 | 23 | M4500 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | INTS7 RBM10 SUN1 ARFGEF2 CCDC90B MSH3 PRPF8 ECH1 GPATCH2L REXO2 LRPPRC ANGEL2 PDE4DIP OSBPL8 MACF1 TAF4 DAAM1 EEA1 HARS1 R3HDM1 HSF2 NIPBL EDRF1 | 1.01e-06 | 1215 | 157 | 23 | M41122 |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 2.97e-06 | 196 | 157 | 9 | M9243 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 5.62e-06 | 212 | 157 | 9 | M39221 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_DN | 6.85e-06 | 21 | 157 | 4 | M12459 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 1.05e-05 | 290 | 157 | 10 | M13251 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.35e-05 | 180 | 157 | 8 | M8239 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 3.52e-05 | 102 | 157 | 6 | M5601 | |
| Coexpression | LEE_CALORIE_RESTRICTION_NEOCORTEX_DN | 5.97e-05 | 69 | 157 | 5 | M1609 | |
| Coexpression | GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP | 6.62e-05 | 166 | 157 | 7 | M344 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | DAPL1 ERCC6L DSP INTS7 PARG WASF3 KIAA0586 ARFGEF2 TFRC RAD50 LRPPRC THADA BRCA2 ETAA1 DGCR8 HSF2 DDX21 RPL7A EDRF1 | 7.54e-06 | 822 | 153 | 19 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | BDP1 KIAA0586 ANKRD26 ARFGEF2 BRCA2 DNAI4 MACF1 NIPBL PLXNA2 | 1.09e-05 | 192 | 153 | 9 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | KIF27 ERCC6L DSP PARG WASF3 ANKRD26 ARFGEF2 ESCO1 TUFT1 TFRC RAD50 LRPPRC BRCA2 MACROD2 DGCR8 HSF2 MGA EDRF1 | 2.65e-05 | 820 | 153 | 18 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ATP5PB TPR METTL3 PHF20 ANK3 ERCC6L CCDC186 ANKRD26 ARFGEF2 MSH3 MAPKAPK5 RAD50 BRCA2 CEP135 ETAA1 DIAPH2 MACF1 R3HDM1 TNNI3 HSF2 NIPBL RPL7A CCDC40 | 2.83e-05 | 1241 | 153 | 23 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 DOCK11 VPS13C PARG ANKRD26 ESCO1 NEK4 SMG7 BRCA2 RABEP1 CEP135 ETAA1 NIPBL CCDC40 | 3.21e-05 | 532 | 153 | 14 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | BDP1 KIAA0586 ANKRD26 ARFGEF2 MAPKAPK5 PPP2R3A BRCA2 MACF1 NIPBL PLXNA2 | 5.13e-05 | 291 | 153 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500 | BDP1 TPR DAPL1 CCDC186 ANKRD26 ARFGEF2 MAPKAPK5 GPR179 BRCA2 FMN1 CEP135 MACF1 DAAM1 | 5.95e-05 | 492 | 153 | 13 | Facebase_RNAseq_e10.5_Mandibular Arch_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | BDP1 TPR CCDC186 ARFGEF2 BRCA2 FMN1 RABEP1 CEP135 MACF1 NIPBL | 6.25e-05 | 298 | 153 | 10 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | TPR PHF20 ERCC6L WASF3 KIAA0586 ANKRD26 RAD50 NEK4 BRCA2 RABEP1 CEP135 DIAPH2 DNAI4 MACF1 LSAMP DMD R3HDM1 HSF2 NIPBL CCDC40 | 7.77e-05 | 1060 | 153 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | PHF20 ERCC6L PARG WASF3 KIAA0586 SPATA1 RAD50 TBC1D32 REXO2 LRPPRC THADA BRCA2 FMN1 HSF2 DDX21 MGA RPL7A | 7.81e-05 | 810 | 153 | 17 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 7.81e-05 | 192 | 153 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | BDP1 KIAA0586 ANKRD26 ARFGEF2 RAD50 NEK4 BRCA2 RABEP1 CEP135 NIPBL | 8.91e-05 | 311 | 153 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | BDP1 TPR DAPL1 CCDC186 CYTH3 SYNE1 ARFGEF2 EMILIN3 BRCA2 FMN1 STARD9 RABEP1 CEP135 MACF1 NIPBL ABTB2 | 9.68e-05 | 744 | 153 | 16 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ATP5PB TPR METTL3 PHF20 ANK3 DAPL1 ERCC6L CCDC186 ANKRD26 ARFGEF2 MSH3 MAPKAPK5 RAD50 BRCA2 CEP135 ETAA1 DIAPH2 MACF1 R3HDM1 TNNI3 HSF2 NIPBL RPL7A CCDC40 | 1.34e-04 | 1468 | 153 | 24 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | BDP1 PHF20 PARG KIF20A DST BRCA2 FMN1 RABEP1 CEP135 ETAA1 NIPBL CCDC40 | 1.56e-04 | 469 | 153 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#4 | 1.75e-04 | 39 | 153 | 4 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.84e-04 | 73 | 153 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | BDP1 TPR ARPP21 CCDC186 ARFGEF2 GAS7 GPR179 BRCA2 PROM2 FMN1 RABEP1 TP63 CEP135 CCDC68 MACF1 TNNI3 NIPBL CCDC40 | 2.49e-04 | 979 | 153 | 18 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 TPR MED6 PHF20 ERCC6L KIAA0586 ANKRD26 ARFGEF2 RAD50 BRCA2 RABEP1 CIBAR1 CEP135 ETAA1 DIAPH2 MACF1 DMD R3HDM1 HSF2 NIPBL CCDC40 | 2.75e-04 | 1257 | 153 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | BDP1 TPR ARPP21 DOCK11 CCDC186 SYNE1 ARFGEF2 GPR179 RAD50 BRCA2 PROM2 FMN1 TP63 CCDC68 MACF1 MGA NIPBL RPL7A | 2.82e-04 | 989 | 153 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | PARG ANKRD26 ARFGEF2 ESCO1 TFRC RAD50 LRPPRC BRCA2 HSF2 EDRF1 | 2.98e-04 | 361 | 153 | 10 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 KIAA0586 ANKRD26 R3HDM2 MSH3 RAD50 NEK4 BRCA2 RABEP1 CEP135 DNAI4 LSAMP EEA1 DMD ARHGEF26 NIPBL | 3.38e-04 | 831 | 153 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | BDP1 TPR DAPL1 CCDC186 CYTH3 SYNE1 ANKRD26 ARFGEF2 EMILIN3 MAPKAPK5 BRCA2 FMN1 STARD9 CEP135 MACF1 ABTB2 | 3.51e-04 | 834 | 153 | 16 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.90e-04 | 243 | 153 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 4.09e-04 | 186 | 153 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | alpha beta T cells, T.8Nve.PP, TCR+ CD8+ CD44low CD62Lhigh, Peyer's Patch, avg-1 | 5.01e-04 | 317 | 153 | 9 | GSM538412_500 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | CCDC186 VPS13C ANKRD26 RAD50 ANKRD36B FHAD1 REXO2 OSBPL8 ANKRD36 EEA1 ARHGAP18 NIPBL | 8.10e-12 | 199 | 159 | 12 | 61b1ed2db71b96157b92b7535d1955a4033098da |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | TPR CCDC186 VPS13C RAD50 DST CCDC68 OSBPL8 ANKRD36 EEA1 UTRN NIPBL | 1.57e-10 | 199 | 159 | 11 | c425e7975f492ed5cfcca022248adb627e1d27d4 |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-09 | 184 | 159 | 10 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 191 | 159 | 10 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 191 | 159 | 10 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-09 | 191 | 159 | 10 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | TPR CCDC186 VPS13C ANKRD26 RAD50 FHAD1 REXO2 OSBPL8 EEA1 NIPBL | 2.75e-09 | 199 | 159 | 10 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-08 | 176 | 159 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | BDP1 ARPP21 ANK3 ARFGEF3 KIDINS220 MACROD2 LSAMP DAAM1 R3HDM1 | 4.34e-08 | 199 | 159 | 9 | f09b40245d3d826275bbe5f508dedccc75a911bd |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.34e-08 | 199 | 159 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | BDP1 ARPP21 ANK3 ARFGEF3 KIDINS220 MACROD2 LSAMP DAAM1 R3HDM1 | 4.34e-08 | 199 | 159 | 9 | e45448ec4db8875c8aaa9aad109a10e2905a4226 |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 4.34e-08 | 199 | 159 | 9 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 4.34e-08 | 199 | 159 | 9 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.53e-08 | 200 | 159 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | BDP1 ARPP21 ANK3 ARFGEF3 KIDINS220 MACROD2 LSAMP DAAM1 R3HDM1 | 4.53e-08 | 200 | 159 | 9 | db10f76938af553d1a2275bb02ef75dff3c3135b |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | BDP1 ARPP21 ANK3 ARFGEF3 KIDINS220 MACROD2 LSAMP DAAM1 R3HDM1 | 4.53e-08 | 200 | 159 | 9 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.20e-07 | 174 | 159 | 8 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.73e-07 | 179 | 159 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.50e-07 | 185 | 159 | 8 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.12e-07 | 189 | 159 | 8 | fe958fdf9963c2dfe270f67f0da36b3264d0017c | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-07 | 190 | 159 | 8 | 9ffd18ef358f8e32c610ab6420f479067c8ba44b | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.29e-07 | 190 | 159 | 8 | 3ef39d61c98de4e5df946b995847aa65eba6a4b6 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.47e-07 | 191 | 159 | 8 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 5.03e-07 | 194 | 159 | 8 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 5.22e-07 | 195 | 159 | 8 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.22e-07 | 195 | 159 | 8 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | (05)_Ciliated|World / shred by cell type and Timepoint | 5.64e-07 | 197 | 159 | 8 | fee3cd16af8eea697cd64e8f64af505aaa2ac4b0 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 5.64e-07 | 197 | 159 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.64e-07 | 197 | 159 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.86e-07 | 198 | 159 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.33e-07 | 200 | 159 | 8 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-06 | 150 | 159 | 7 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 162 | 159 | 7 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-06 | 162 | 159 | 7 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.24e-06 | 175 | 159 | 7 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-06 | 176 | 159 | 7 | ed788a5969edfd1199828ca5b0dd34e7f29c4d30 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-06 | 177 | 159 | 7 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.49e-06 | 177 | 159 | 7 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-06 | 179 | 159 | 7 | d4efbc34f52136039b96451fd0b0a0ad164197c6 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-tracheobronchial_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.76e-06 | 179 | 159 | 7 | 8a66d197a2f55d763ff7ef0bec89ee96f59c3937 | |
| ToppCell | Mild/Remission-B_intermediate-10|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.35e-06 | 183 | 159 | 7 | 278064c9f0582463b83bf156d34e77f60187613b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.51e-06 | 184 | 159 | 7 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 184 | 159 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.51e-06 | 184 | 159 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.84e-06 | 186 | 159 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 5.01e-06 | 187 | 159 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 5.19e-06 | 188 | 159 | 7 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-06 | 188 | 159 | 7 | 0eca3dc93724e23b71e687fc24fa9f1e89bdef6a | |
| ToppCell | droplet-Lung-18m-Epithelial-airway_epithelial-lung_ciliated_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.19e-06 | 188 | 159 | 7 | 9ce3e1fffce87ad19812ecbf9b7f9935a975d676 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-06 | 189 | 159 | 7 | 28c750ac56e3861fe7280e32839a4d8ce8bd8692 | |
| ToppCell | droplet-Lung-1m-Epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.38e-06 | 189 | 159 | 7 | 72ecd5a10e419bac475e22f5b602e7f008835ce9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-06 | 189 | 159 | 7 | efee01edd171bf569267b672fab05c421de6c92d | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 190 | 159 | 7 | 088e3f39a1e5e11354d6e7458e8e6a39f14936b3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-06 | 190 | 159 | 7 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 190 | 159 | 7 | 35248a8be476ea8d06d67c3d98a25be1f7c150b7 | |
| ToppCell | PND14-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.57e-06 | 190 | 159 | 7 | 5f5206f9e725070d865f4c891ff08bb750e58582 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 5.57e-06 | 190 | 159 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 5.76e-06 | 191 | 159 | 7 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 191 | 159 | 7 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 191 | 159 | 7 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 191 | 159 | 7 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-06 | 191 | 159 | 7 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | Ciliated-cil-3|World / Class top | 5.96e-06 | 192 | 159 | 7 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.96e-06 | 192 | 159 | 7 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 6.17e-06 | 193 | 159 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-06 | 194 | 159 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.38e-06 | 194 | 159 | 7 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.60e-06 | 195 | 159 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.60e-06 | 195 | 159 | 7 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.60e-06 | 195 | 159 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.82e-06 | 196 | 159 | 7 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 196 | 159 | 7 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.82e-06 | 196 | 159 | 7 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.05e-06 | 197 | 159 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.05e-06 | 197 | 159 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.05e-06 | 197 | 159 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-06 | 198 | 159 | 7 | e125eb8aa57c172e5518874da1bd25998292f5e2 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 7.29e-06 | 198 | 159 | 7 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.29e-06 | 198 | 159 | 7 | 0baeb8e2c199ff10bb5c829c523546af3c9227c1 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.29e-06 | 198 | 159 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 7.29e-06 | 198 | 159 | 7 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 7.53e-06 | 199 | 159 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.53e-06 | 199 | 159 | 7 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 7.53e-06 | 199 | 159 | 7 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 7.53e-06 | 199 | 159 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.78e-06 | 200 | 159 | 7 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.78e-06 | 200 | 159 | 7 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_3|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.78e-06 | 200 | 159 | 7 | 06b59ee536414d1f73c1e17cdfd7c3f2259b9bef | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.78e-06 | 200 | 159 | 7 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.78e-06 | 200 | 159 | 7 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.78e-06 | 200 | 159 | 7 | 061ba851f941c616ddb462512e826c412881c3ce | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.53e-06 | 136 | 159 | 6 | edfd453c9a650d69d05a5a3ab15f7df56349fa86 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.53e-06 | 136 | 159 | 6 | 03e4e2353c23ceffde35b2d0aadd15299e3db09f | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-06 | 137 | 159 | 6 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-05 | 153 | 159 | 6 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 161 | 159 | 6 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | Control-B_intermediate-10|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.57e-05 | 162 | 159 | 6 | aa80452b972bb8ad3670ffaba4ce26fadb33b185 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-05 | 167 | 159 | 6 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | ANK3 CCDC186 SUN1 MYO1B PPP2R3A KIDINS220 PDE4DIP TLN2 R3HDM1 HSF2 | 5.41e-07 | 180 | 158 | 10 | 7356_UP |
| Drug | Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A | TPR MED6 ANK3 KIAA0586 SMG7 RABEP1 PDE4DIP ENTPD5 MACF1 SYMPK | 9.31e-07 | 191 | 158 | 10 | 4811_DN |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | KIAA0586 GPATCH2L RAD50 PPP2R3A SMG7 TLN1 PDE4DIP EEA1 NIPBL ABTB2 | 1.12e-06 | 195 | 158 | 10 | 5004_DN |
| Drug | Clorgyline | 2.74e-06 | 168 | 158 | 9 | ctd:D003010 | |
| Drug | Phpc-1,2 | 3.25e-06 | 5 | 158 | 3 | CID000173570 | |
| Drug | 14-fluororetinal | 3.25e-06 | 5 | 158 | 3 | CID006438634 | |
| Drug | 10,20-methanoretinal | 3.25e-06 | 5 | 158 | 3 | CID006438558 | |
| Drug | trans-retinoyl chloromethane | 3.25e-06 | 5 | 158 | 3 | CID006439860 | |
| Drug | 9,11-dcfr | 3.25e-06 | 5 | 158 | 3 | CID006443659 | |
| Drug | 3-hydroxyretinal | 6.46e-06 | 6 | 158 | 3 | CID000151436 | |
| Drug | 7,8-Dhr | 6.46e-06 | 6 | 158 | 3 | CID006443426 | |
| Drug | AC1NTD7Z | 6.46e-06 | 6 | 158 | 3 | CID005378594 | |
| Drug | 5,6-epoxy-3-dehydroretinal | 6.46e-06 | 6 | 158 | 3 | CID006449988 | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; PC3; HT_HG-U133A | 8.49e-06 | 193 | 158 | 9 | 6717_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 4686_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 3269_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 7393_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 2517_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 9.22e-06 | 195 | 158 | 9 | 2311_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; HL60; HT_HG-U133A | 9.61e-06 | 196 | 158 | 9 | 2936_DN | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A | ANK3 C11orf16 GPATCH2L RHO EPS15L1 KIDINS220 CIBAR1 PDE4DIP SNCG | 1.00e-05 | 197 | 158 | 9 | 2568_UP |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; HL60; HT_HG-U133A | 1.00e-05 | 197 | 158 | 9 | 2494_DN | |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | METTL3 KIAA0586 ANKRD26 ARFGEF2 ANGEL2 PDE4DIP TLN2 HSF2 NIPBL | 1.00e-05 | 197 | 158 | 9 | 2300_DN |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.04e-05 | 198 | 158 | 9 | 4601_UP | |
| Drug | 4-n-butylaniline | 1.12e-05 | 7 | 158 | 3 | CID000007694 | |
| Drug | (-)-MK 801 hydrogen maleate [77086-19-2]; Up 200; 11.8uM; HL60; HT_HG-U133A | 1.13e-05 | 200 | 158 | 9 | 3081_UP | |
| Drug | geldanamycin | BDP1 TPR CCDC186 ESCO1 DST RABEP1 PDE4DIP OSBPL8 EEA1 DMD NIPBL PLXNA2 | 1.15e-05 | 371 | 158 | 12 | ctd:C001277 |
| Drug | plakin | 2.30e-05 | 82 | 158 | 6 | CID000018752 | |
| Drug | Thimerosal | BDP1 TPR ANKRD35 PHF20 RASA2 DOCK11 CCDC186 ESCO1 CC2D2B ARFGEF3 FSIP2 LRPPRC DST BRCA2 CIBAR1 OSBPL8 EEA1 TDRD6 ARHGAP18 TNNI3 HSF2 NIPBL | 2.92e-05 | 1199 | 158 | 22 | ctd:D013849 |
| Drug | Photoproduct | 5.19e-05 | 11 | 158 | 3 | CID000500521 | |
| Drug | retinal oxime | 5.19e-05 | 11 | 158 | 3 | CID009577279 | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; MCF7; HT_HG-U133A | 6.05e-05 | 192 | 158 | 8 | 7004_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.05e-05 | 192 | 158 | 8 | 993_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; PC3; HT_HG-U133A | 6.28e-05 | 193 | 158 | 8 | 5764_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A | 6.28e-05 | 193 | 158 | 8 | 5758_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 6.51e-05 | 194 | 158 | 8 | 4169_DN | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 6.51e-05 | 194 | 158 | 8 | 4301_DN | |
| Drug | Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 4647_UP | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 5269_DN | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 3135_DN | |
| Drug | Nizatidine [76963-41-2]; Down 200; 12uM; HL60; HT_HG-U133A | 6.75e-05 | 195 | 158 | 8 | 3047_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 5425_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.99e-05 | 196 | 158 | 8 | 4591_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 3862_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 3708_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 7036_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 7.25e-05 | 197 | 158 | 8 | 6063_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 1491_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 3405_UP | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 7031_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 500uM; PC3; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 4464_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 2424_UP | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 7.51e-05 | 198 | 158 | 8 | 2821_DN | |
| Drug | Isopropamide iodide [71-81-8]; Up 200; 8.4uM; PC3; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 7133_UP | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 4806_DN | |
| Drug | Sulfadoxine [2447-57-6]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 7205_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; HL60; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 2732_DN | |
| Drug | Tobramycin [32986-56-4]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 199 | 158 | 8 | 2841_DN | |
| Drug | Idoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HG-U133A | 8.05e-05 | 200 | 158 | 8 | 1899_UP | |
| Drug | Maprotiline hydrochloride [10347-81-6]; Down 200; 12.8uM; PC3; HT_HG-U133A | 8.05e-05 | 200 | 158 | 8 | 6676_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; PC3; HT_HG-U133A | 8.05e-05 | 200 | 158 | 8 | 6679_DN | |
| Drug | AC1L28XQ | 1.13e-04 | 14 | 158 | 3 | CID000068054 | |
| Drug | NSC3364 | 1.76e-04 | 118 | 158 | 6 | CID000025439 | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.18e-04 | 174 | 158 | 7 | 1019_UP | |
| Drug | IDETA | 2.85e-04 | 4 | 158 | 2 | CID003036201 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 2.87e-04 | 182 | 158 | 7 | 1891_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.87e-04 | 182 | 158 | 7 | 1043_DN | |
| Drug | pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A | 2.97e-04 | 183 | 158 | 7 | 7088_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 3.17e-04 | 185 | 158 | 7 | 5439_DN | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 3.28e-04 | 186 | 158 | 7 | 6987_UP | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 3.39e-04 | 187 | 158 | 7 | 4323_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; MCF7; HT_HG-U133A | 3.61e-04 | 189 | 158 | 7 | 4688_UP | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 3.61e-04 | 189 | 158 | 7 | 3788_DN | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.73e-04 | 190 | 158 | 7 | 5271_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 3.85e-04 | 191 | 158 | 7 | 3890_DN | |
| Drug | Bupivacaine hydrochloride [18010-40-7]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 3.85e-04 | 191 | 158 | 7 | 7435_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 3.97e-04 | 192 | 158 | 7 | 1599_DN | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; MCF7; HT_HG-U133A | 3.97e-04 | 192 | 158 | 7 | 7092_DN | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 3.97e-04 | 192 | 158 | 7 | 6188_DN | |
| Drug | iodine monochloride | 3.98e-04 | 21 | 158 | 3 | CID000024640 | |
| Drug | mant-GTP | 4.01e-04 | 50 | 158 | 4 | CID000128647 | |
| Drug | Lasalocid sodium salt [25999-20-6]; Up 200; 6.6uM; HL60; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 3021_UP | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 5101_DN | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; HL60; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 3057_DN | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 4.09e-04 | 193 | 158 | 7 | 948_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 6643_UP | |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; PC3; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 4569_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; HL60; HT_HG-U133A | 4.09e-04 | 193 | 158 | 7 | 2202_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 6833_DN | |
| Drug | Estrone [53-16-7]; Down 200; 14.8uM; PC3; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 6647_DN | |
| Drug | Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 3280_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 4.22e-04 | 194 | 158 | 7 | 6778_DN | |
| Drug | Clopamide [636-54-4]; Up 200; 11.6uM; PC3; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 6301_UP | |
| Drug | Fillalbin [4540-25-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 4092_DN | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 6224_UP | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; HL60; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 2932_UP | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 4781_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 2719_DN | |
| Drug | Piromidic acid [19562-30-2]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.36e-04 | 195 | 158 | 7 | 4398_DN | |
| Drug | Atovaquone [95233-18-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 4.49e-04 | 196 | 158 | 7 | 4786_DN | |
| Disease | blue cone monochromacy (implicated_via_orthology) | 7.32e-10 | 4 | 155 | 4 | DOID:0050679 (implicated_via_orthology) | |
| Disease | Cone monochromatism | 2.74e-05 | 2 | 155 | 2 | cv:C0339537 | |
| Disease | BORNHOLM EYE DISEASE | 2.74e-05 | 2 | 155 | 2 | C3159311 | |
| Disease | Achromatopsia incomplete, X-linked | 2.74e-05 | 2 | 155 | 2 | C2931753 | |
| Disease | Red-green dyschromatopsia | 2.74e-05 | 2 | 155 | 2 | cv:C0155016 | |
| Disease | Cone monochromatism | 2.74e-05 | 2 | 155 | 2 | C0339537 | |
| Disease | BLUE CONE MONOCHROMACY | 2.74e-05 | 2 | 155 | 2 | 303700 | |
| Disease | blue cone monochromacy (is_implicated_in) | 2.74e-05 | 2 | 155 | 2 | DOID:0050679 (is_implicated_in) | |
| Disease | wellbeing measurement, alcohol consumption measurement | 4.51e-05 | 74 | 155 | 5 | EFO_0007869, EFO_0007878 | |
| Disease | Malignant Squamous Cell Neoplasm | 8.20e-05 | 3 | 155 | 2 | C0751688 | |
| Disease | Squamous Cell Neoplasms | 8.20e-05 | 3 | 155 | 2 | C0206720 | |
| Disease | Other restrictive cardiomyopathy | 2.71e-04 | 5 | 155 | 2 | C0348616 | |
| Disease | pancreatic carcinoma | 3.26e-04 | 174 | 155 | 6 | EFO_0002618 | |
| Disease | restrictive cardiomyopathy (is_implicated_in) | 4.06e-04 | 6 | 155 | 2 | DOID:397 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 5.60e-04 | 268 | 155 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | response to tamsulosin | 5.66e-04 | 7 | 155 | 2 | GO_1901905 | |
| Disease | Ectrodactyly | 5.66e-04 | 7 | 155 | 2 | C0265554 | |
| Disease | infertility (implicated_via_orthology) | 5.66e-04 | 7 | 155 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | primary ovarian insufficiency (is_implicated_in) | 7.52e-04 | 8 | 155 | 2 | DOID:5426 (is_implicated_in) | |
| Disease | coronary aneurysm | 8.22e-04 | 35 | 155 | 3 | EFO_1000881 | |
| Disease | cognitive disorder (is_implicated_in) | 9.63e-04 | 9 | 155 | 2 | DOID:1561 (is_implicated_in) | |
| Disease | orofacial cleft | 9.69e-04 | 37 | 155 | 3 | MONDO_0000358 | |
| Disease | unipolar depression, bipolar disorder | 1.43e-03 | 156 | 155 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | dilated cardiomyopathy (is_implicated_in) | 1.50e-03 | 43 | 155 | 3 | DOID:12930 (is_implicated_in) | |
| Disease | Night blindness, congenital stationary, type 1 | 1.75e-03 | 12 | 155 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.75e-03 | 12 | 155 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.75e-03 | 12 | 155 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.75e-03 | 12 | 155 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.75e-03 | 12 | 155 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.75e-03 | 12 | 155 | 2 | C1848172 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 2.01e-03 | 101 | 155 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | liver cirrhosis (implicated_via_orthology) | 2.06e-03 | 13 | 155 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | sensory peripheral neuropathy, response to platinum based chemotherapy | 2.06e-03 | 13 | 155 | 2 | EFO_0004647, MONDO_0002321 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 2.06e-03 | 13 | 155 | 2 | C4041558 | |
| Disease | Hyperlipoproteinemia Type IIb | 2.06e-03 | 13 | 155 | 2 | C1704417 | |
| Disease | Hamman-Rich syndrome | 2.39e-03 | 14 | 155 | 2 | C0085786 | |
| Disease | age at last pregnancy measurement | 2.39e-03 | 14 | 155 | 2 | EFO_0009440 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.39e-03 | 14 | 155 | 2 | C0677776 | |
| Disease | disease recurrence, colon carcinoma | 2.46e-03 | 51 | 155 | 3 | EFO_0004952, EFO_1001950 | |
| Disease | Hepatitis | 2.75e-03 | 15 | 155 | 2 | C0019158 | |
| Disease | third ventricle volume measurement | 2.75e-03 | 15 | 155 | 2 | EFO_0010335 | |
| Disease | Hyperlipoproteinemia Type IIa | 3.13e-03 | 16 | 155 | 2 | C0745103 | |
| Disease | ovarian cancer (is_implicated_in) | 3.21e-03 | 56 | 155 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | Night blindness, congenital stationary | 3.54e-03 | 17 | 155 | 2 | C0339535 | |
| Disease | Fetal Alcohol Syndrome | 3.54e-03 | 17 | 155 | 2 | C0015923 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.68e-03 | 194 | 155 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | nevus count | 3.97e-03 | 18 | 155 | 2 | EFO_0004632 | |
| Disease | Hypercholesterolemia, Familial | 3.97e-03 | 18 | 155 | 2 | C0020445 | |
| Disease | Colorectal Carcinoma | 4.09e-03 | 702 | 155 | 10 | C0009402 | |
| Disease | IGF-1 measurement | 4.39e-03 | 488 | 155 | 8 | EFO_0004627 | |
| Disease | Usual Interstitial Pneumonia | 4.42e-03 | 19 | 155 | 2 | C4721509 | |
| Disease | Hamman-Rich Disease | 4.42e-03 | 19 | 155 | 2 | C4721508 | |
| Disease | Malignant neoplasm of breast | KDM3A KIF6 ATP7B SYNE1 ARFGEF2 MANEA TFRC BRCA2 MACF1 DMD SNCG NIPBL PADI3 | 4.49e-03 | 1074 | 155 | 13 | C0006142 |
| Disease | Headache | 4.69e-03 | 64 | 155 | 3 | HP_0002315 | |
| Disease | corneal hysteresis | 4.90e-03 | 20 | 155 | 2 | EFO_0010066 | |
| Disease | Familial Idiopathic Pulmonary Fibrosis | 4.90e-03 | 20 | 155 | 2 | C4721952 | |
| Disease | bone mineral content measurement | 4.99e-03 | 130 | 155 | 4 | EFO_0007621 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KTQIQSQESDLKSQE | 481 | Q9UBC2 | |
| STIGKKSVQTISNEQ | 306 | P41595 | |
| KSVQTISNEQRASKV | 311 | P41595 | |
| DETEKKVLTVSNSQI | 1611 | A6H8Y1 | |
| SKTNETEQKVTQILV | 106 | Q7Z3E2 | |
| TTTKLTQAKEEADQI | 416 | Q7Z3E2 | |
| DTVVQQVTKRTQESK | 91 | Q96NH3 | |
| KVIKSQLNVSSVSEQ | 61 | Q13686 | |
| QSIQVSLENKTAQVK | 286 | P35670 | |
| TIATKSTKQNVASEK | 836 | Q9Y6D5 | |
| STNKLEKQILDQTSE | 166 | O15123 | |
| EKKIVTATVNNSVLQ | 231 | O15123 | |
| STEDVILKTEQVTKN | 641 | Q9Y2X7 | |
| LAKTTQETIDKTANQ | 46 | Q15847 | |
| ASEIKISKSNNQNVE | 256 | Q96DR7 | |
| SVSNIATEIKKGQQS | 596 | A6QL64 | |
| VSSQKQQALKATTDE | 391 | Q8N2N9 | |
| KATIENKDSVLNTAT | 706 | Q8N2N9 | |
| STQELKKQQQAAATV | 381 | Q8N283 | |
| QKLEKSTAQISQAVT | 656 | P11532 | |
| QKVKQQTAVSETFSE | 1151 | Q5TGY3 | |
| LQKTIKQNEETLTQT | 956 | Q9UPS8 | |
| QTQLKQTEVLVTAEK | 426 | Q5VTE6 | |
| QNKELKTQVALSSET | 291 | Q9H2F9 | |
| VKQETSDKSVIELQQ | 706 | Q8WYQ5 | |
| VESASKVSAQILKSN | 901 | O60879 | |
| QTKSIISETSNKIDA | 201 | Q9GZT6 | |
| SQKEKEVSVSDVNSI | 766 | Q6DHV5 | |
| IQTLQEETKKVQAET | 121 | Q6ZUS5 | |
| EKTSAIANVAKIQTL | 46 | A0PJW8 | |
| NVDQTGKSVIINKTS | 211 | Q9UBL0 | |
| KHVVQSISTQQEKET | 221 | P24539 | |
| VDQAITKKDQSQVLT | 741 | Q9UPM8 | |
| VDQSGKSVIVNKTSN | 216 | Q15032 | |
| NVDQTGKAVIINKTS | 216 | Q9Y2K5 | |
| LSSSNVRVIKDKQTQ | 326 | P98175 | |
| IRAVAKQQKESESTQ | 246 | P04000 | |
| IRAVAKQQKESESTQ | 246 | P0DN78 | |
| IEDSVTTFKTIQQIK | 801 | Q15283 | |
| QITSKEAQLTSSKEI | 226 | Q92878 | |
| ENIKAIATVSENTKQ | 86 | Q15276 | |
| VSKVVAKVQDLSSQV | 326 | Q68DA7 | |
| SVESKAVIKQQLESV | 506 | Q9NVH2 | |
| QQQESATTQKAEKEV | 236 | P08100 | |
| IRAVAKQQKESESTQ | 246 | P0DN77 | |
| TITNIREKNSQASKV | 416 | Q9H1A4 | |
| VSSEDSKRQINQKDT | 181 | P20585 | |
| QDSSIEISKLTDKVQ | 1366 | Q9ULH0 | |
| STVLQLTKKVNNIET | 396 | O75356 | |
| QQLKESQTEVNAKAS | 396 | Q9Y250 | |
| TEKQASQVTKQIALA | 121 | Q8IW41 | |
| SVKNTTEQEILKAIN | 536 | Q9NPP4 | |
| VRTISEKASNKTVQN | 2086 | Q8IWI9 | |
| TVKAVQKLSQQQESV | 1521 | Q6PRD1 | |
| QQSSSQKDEILQTVK | 286 | Q6UWE0 | |
| QVVKQITDNTSSKQD | 3116 | Q9UKN7 | |
| TSNNIEDDTILKTNK | 1181 | Q3B7T1 | |
| TDTEAVKTQVEQNKS | 4546 | Q03001 | |
| VQVDEQKTQALQSTK | 561 | Q8WWW8 | |
| KITSKVLNSVQEFIS | 6211 | Q5CZC0 | |
| SINVVLKSVQEQTEK | 836 | Q12766 | |
| LKSVQEQTEKTLTSE | 841 | Q12766 | |
| KNVQLQTSTAEEKTK | 1001 | Q86VH2 | |
| QTSTAEEKTKISEQV | 1006 | Q86VH2 | |
| KESVNVCKVVNTTTL | 1081 | O75051 | |
| LTTVKLANAKQTTED | 211 | Q86W56 | |
| KVDVTSTQKEAENQR | 576 | P51957 | |
| VQATTENKELKTVTF | 311 | Q13011 | |
| DSNKKIDQDVVITNS | 1516 | Q6KC79 | |
| KILENNTVSSESKDQ | 436 | Q6ZMV9 | |
| TVEEKSTKVNNKNEQ | 441 | Q7Z3Y8 | |
| KEAVTTLKTVLDQQQ | 1121 | P42704 | |
| LTKDVTTSVLIVNNK | 201 | Q14749 | |
| KVNITVVAESKQSSA | 856 | Q6IE36 | |
| EQVKTISINQVLSNK | 521 | Q9ULW8 | |
| DKAKDTTSAVLIQQT | 646 | Q06190 | |
| RINSETNTKNLKSVE | 66 | Q5SRI9 | |
| EAVTSALQQETEKSK | 3726 | Q9UPN3 | |
| QQSTKEQQSKKVSQE | 231 | Q86U44 | |
| TQQQDIRKDSKTSES | 621 | Q9NY74 | |
| QQQDIRKDSKTSESI | 651 | Q9NY74 | |
| IRAVAKQQKESESTQ | 246 | P04001 | |
| LTKAVKESTITLQQA | 106 | Q9Y3B8 | |
| QSSIESIKQTQEEIK | 831 | Q9BZF1 | |
| EDSIRKQQVSDSTKN | 356 | Q9H3D4 | |
| VTSEVVNLSNKNEKL | 301 | Q66GS9 | |
| NVIAQSLSTENIKTK | 206 | Q9Y4D1 | |
| QVTQLTEKLKNQSES | 576 | Q15075 | |
| ATAQEIIKSQAIATK | 4471 | P04114 | |
| QKVSETTTSRQNEKE | 266 | B1AJZ9 | |
| SQNLKESSVKVDNES | 481 | Q9Y4C1 | |
| IQINTDSLVQEKKET | 271 | Q5JSL3 | |
| SDKVSTQVLQKSRDV | 1346 | Q8NF50 | |
| QKNQEETTSISKITV | 861 | P51587 | |
| NKTSSADTQKVAIIE | 2706 | P51587 | |
| AQTKQLQTAVSNVEK | 11 | A1XBS5 | |
| SQGKIVSTQEKELVQ | 326 | Q86TI2 | |
| LTNQETITAEQVKKV | 1826 | Q5TH69 | |
| NATQESQKKIINEAS | 806 | Q8N3K9 | |
| IIQKVAKSASEETNT | 416 | Q96A23 | |
| SLKNQFETEINITKT | 1361 | P15924 | |
| DVKKVNELITNSQSE | 701 | Q4G0X9 | |
| KESKLVTNQSTSEDQ | 396 | Q9HC77 | |
| TSVEESKTTQRNKQI | 56 | O43739 | |
| EQAKSTSLKQTTVEE | 3211 | Q12955 | |
| VKQSVVESSSKANVL | 336 | Q5VTH9 | |
| TSEVAASLQQKLKVS | 136 | Q9NWQ4 | |
| NDKATKSINKNTVTV | 76 | Q5FWF5 | |
| NVQLSLTEATEKAKQ | 176 | P38567 | |
| ILSKVTEVSNTLQTK | 251 | Q9NT22 | |
| DTKNTRQDNSILKVT | 126 | Q5T9C2 | |
| SKSAVQNKVVVITDA | 31 | A6NNS2 | |
| ETKKEAQELSQNSAI | 446 | Q9NR30 | |
| TTETQVLVASAQKKL | 406 | P12081 | |
| KQDLSSIKVNVTTLQ | 786 | Q2NKX8 | |
| EEKETTKNVQQTVSA | 221 | O75586 | |
| SSAQKVQIKQETIES | 131 | Q03933 | |
| QEISTVEVTNTFKKT | 421 | Q9BVI0 | |
| ENTQETSQVKKSLTE | 56 | A1Z1Q3 | |
| LVQQVDKTKEVTTTG | 11 | O95397 | |
| GAKTKENVVQSVTSV | 41 | O76070 | |
| ENVVQSVTSVAEKTK | 46 | O76070 | |
| SVTSVAEKTKEQANA | 51 | O76070 | |
| KQSTETAANVKELVQ | 611 | O00268 | |
| LNSQSVEITKLQTEK | 801 | O60763 | |
| QTSNFKDQKELSVSV | 556 | P46939 | |
| KILQTSIDAKTGQEQ | 566 | Q6YHU6 | |
| EKSQVELSTQVIKSA | 1481 | O60522 | |
| NASVKTTAKDIQQTE | 4101 | Q8NF91 | |
| QASVNTIIEKVNKLT | 4186 | Q8NF91 | |
| LIAKQQAIKIETTSS | 221 | Q969N4 | |
| NEVSSADVKQVKVTV | 201 | Q13449 | |
| NTVTTLVENKKAQLV | 141 | P62424 | |
| KKQSKENTITINCVT | 166 | O60861 | |
| TGKQNVAVQVKSQTE | 606 | Q92540 | |
| QKDVSQSSISFQIEK | 486 | Q02383 | |
| QKEIRVSSLNKVSSQ | 2471 | Q9P2P6 | |
| VTQSEIAQKQKLQTV | 146 | Q9NVD7 | |
| VTSESKNVKLTVSNV | 366 | P02786 | |
| KLNTISTEVVNKFIS | 51 | Q5VX52 | |
| KTSKNDSVIQQLATI | 796 | Q8N961 | |
| SIISENEKTSKVNSV | 406 | Q8TBZ0 | |
| NEKTSKVNSVTEQCV | 411 | Q8TBZ0 | |
| KTAKDALSSVQESQV | 41 | P02656 | |
| KQQRAQTAVVGTTKE | 416 | Q9NQ32 | |
| IVKDATTIAKIQQST | 881 | P48736 | |
| IAEIEKQTKEQSQLT | 2026 | Q6P2Q9 | |
| VKTQSQNQHITEVEK | 2396 | A4UGR9 | |
| NSKAVIQSKDATIQE | 311 | Q9NNX1 | |
| GNQQVVDTSLKQTVK | 126 | Q7Z417 | |
| TSSVVQELKKAVAQQ | 366 | Q8N271 | |
| LKKTLSSVQNEVQEA | 1036 | P12270 | |
| AASASTQQLQEVKAK | 681 | O95235 | |
| EVANSTANLVKTIKA | 1531 | Q9Y490 | |
| QEKLISSAKQVAAST | 2421 | Q9Y490 | |
| KTVSKLVIQNANVSA | 516 | P35916 | |
| FKSSTVQDQQVVSKN | 101 | Q9UPY6 | |
| VEQFQLSISTEVKKS | 21 | A0A0A0MS01 | |
| EQATTIFQSEQGKKT | 816 | P55017 | |
| SVAKEVQISTEKQQK | 1051 | Q709C8 | |
| KKSSENSQEDQEVVV | 86 | Q8N392 | |
| DSQKTKENNQVIVST | 871 | Q2VWA4 | |
| KENNQVIVSTKDDNS | 876 | Q2VWA4 | |
| ITNDSKITVLKQVQE | 46 | Q92797 | |
| AKVTKNITEIADLTQ | 116 | P19429 | |
| VKAINEVDDTSKQTT | 181 | Q6P2C0 | |
| AKEVANSTANLVKTI | 1531 | Q9Y4G6 | |
| LQTIVAVAEQKNKTS | 221 | Q96LJ8 | |
| LEQTKQKTISAVGEQ | 456 | O94901 | |
| LKVSSQIDTQDSSVK | 66 | Q16600 | |
| TKTENEEKTAQLNIS | 86 | Q8N2I2 | |
| DIRTNTQDKTVNKSV | 566 | Q9BVV6 | |
| IQKSSIEKCSVDIQQ | 66 | Q12918 | |
| AKQEKVSTTLNVAQA | 331 | O43795 | |
| TGESLVKQDSKQIQV | 1256 | Q5VU43 | |
| QVTQAKKSQAIASDV | 901 | P20929 | |
| LSVVAAKKSQEVATN | 1876 | P20929 |